Antengene Corporation Limited

DB:722 Stock Report

Market Cap: €347.6m

Antengene Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Jay Mei

Chief executive officer

CN¥13.9m

Total compensation

CEO salary percentage46.67%
CEO tenure6yrs
CEO ownership25.9%
Management average tenure3.1yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jay Mei's remuneration changed compared to Antengene's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025CN¥14mCN¥6m

-CN¥239m

Sep 30 2025n/an/a

-CN¥234m

Jun 30 2025n/an/a

-CN¥229m

Mar 31 2025n/an/a

-CN¥274m

Dec 31 2024CN¥13mCN¥6m

-CN¥319m

Sep 30 2024n/an/a

-CN¥424m

Jun 30 2024n/an/a

-CN¥530m

Mar 31 2024n/an/a

-CN¥555m

Dec 31 2023CN¥17mCN¥6m

-CN¥581m

Sep 30 2023n/an/a

-CN¥628m

Jun 30 2023n/an/a

-CN¥676m

Mar 31 2023n/an/a

-CN¥639m

Dec 31 2022CN¥15mCN¥6m

-CN¥601m

Sep 30 2022n/an/a

-CN¥584m

Jun 30 2022n/an/a

-CN¥567m

Mar 31 2022n/an/a

-CN¥611m

Dec 31 2021CN¥17mCN¥5m

-CN¥656m

Compensation vs Market: Jay's total compensation ($USD2.06M) is above average for companies of similar size in the German market ($USD1.05M).

Compensation vs Earnings: Jay's compensation has increased whilst the company is unprofitable.

CEO

Jay Mei (61 yo)

6yrs
Tenure
CN¥13,900,000
Compensation

Dr. Jay Mei, M.D. & Ph.D. is the Founder of Antengene Corporation and serves as Chairman and Chief Executive Officer since August 18, 2020. He has been Director of Antengene Corporation since August 28, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Jay Mei
Founder6yrsCN¥13.90m25.93%
€ 90.1m
Yiteng Liu
Chief Operating Officer6yrsno datano data
Thomas Karalis
Corporate VP & Head of Asia Pacific Region6.3yrsno datano data
Rui Guo
Chief Business Officerno datano datano data
Hou Bing
Chief Scientific Officer & Executive Directorless than a yearno datano data
Shimin Sun
Corporate VP and Head of Clinical Enabling Functions & Operational Excellenceno datano datano data
Dirk Hoenemann
VP and Head of Medical Affairs for APAC & Early Clinical Development6.1yrsno datano data
Ying Liu
Joint Company Secretaryless than a yearno datano data
Chin Hei Hei
Joint Company Secretaryless than a yearno datano data
3.1yrs
Average Tenure
42yo
Average Age

Experienced Management: 722's management team is considered experienced (3.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jay Mei
Founder8yrsCN¥13.90m25.93%
€ 90.1m
Hou Bing
Chief Scientific Officer & Executive Directorno datano datano data
Ricky Johnstone
Member of Scientific Advisory Boardno datano datano data
Shaji K. Kumar
Member of Scientific Advisory Boardno datano datano data
Yi-Long Wu
Member of Scientific Advisory Board3.6yrsno datano data
Robert Gale
Member of Scientific Advisory Boardno datano datano data
Jing Qian
Independent Non-Executive Director5.8yrsCN¥295.00kno data
Sheng Tang
Independent Non-Executive Director5.8yrsCN¥295.00kno data
Rafael Fonseca
Independent Non-Executive Director3.3yrsCN¥269.00kno data
Wei-Li Zhao
Member of Scientific Advisory Boardno datano datano data
Jayesh Desai
Member of Scientific Advisory Board3.6yrsno datano data
3.6yrs
Average Tenure
50yo
Average Age

Experienced Board: 722's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/11 20:28
End of Day Share Price 2026/08/11 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Antengene Corporation Limited is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ziyu HeChina International Capital Corporation Limited
Wangbin ZhouCitigroup Inc
null nullCMB International Securities Limited